Xtant Medical Holdings, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in 2007, the company has established itself as a leader in the development and distribution of innovative spinal and cranial surgical solutions. With a focus on regenerative medicine, Xtant Medical offers a range of core products, including allograft tissue and advanced surgical instruments, designed to enhance patient outcomes.
Operating primarily in North America, Xtant Medical has achieved significant milestones, including strategic acquisitions that have expanded its product portfolio and market reach. Renowned for its commitment to quality and innovation, the company continues to strengthen its position in the competitive landscape of orthopaedic and neurosurgical markets, making it a trusted partner for healthcare professionals worldwide.
-9 vs industry average
Xtant Medical Holdings, Inc.’s score of 13 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Xtant Medical Holdings, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has increased its overall emissions by 7% since 2019
Reported emissions
No reported emissions data is available for Xtant Medical Holdings, Inc. yet.
Xtant Medical Holdings, Inc.'s reported carbon emissions
Xtant Medical Holdings, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company.
As of now, Xtant Medical Holdings, Inc. does not inherit emissions data from any parent or related organisations, meaning all information is self-reported. The company has not established any Science-Based Targets Initiative (SBTi) commitments or other industry-standard climate initiatives.
In the context of the medical device industry, where sustainability and climate commitments are increasingly important, Xtant Medical Holdings, Inc. may need to consider developing a comprehensive strategy to address carbon emissions and set measurable reduction targets in the future.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Xtant Medical Holdings, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Xtant Medical Holdings, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project